Study of Ibrutinib in Patients With Relapsed or Refractory Primary Central Nervous Lymphoma or Intraocular Lymphoma
Clinical trial NCT02542514 · COMPLETED
Trial details
- NCT number
- NCT02542514
- Sponsor
- The Lymphoma Academic Research Organisation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-01
- Primary completion
- 2016-08-01
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.